ARTA
LUMO

A.R.T. Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

A.R.T. Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,008
Closed -$46K – 1061
2019
Q4 		$46K Buy
+2,008
New +$28.6K ﹤0.01% 1252
2019
Q2 		– Sell
-2,397
Closed -$42K – 1685
2019
Q1 		$42K Buy
2,397
+518
+28% +$7.72K ﹤0.01% 1226
2018
Q4 		$26K Buy
+1,879
New +$33.1K ﹤0.01% 1243
2018
Q3 		– Sell
-14,814
Closed -$634K – 1777
2018
Q2 		$634K Buy
+14,814
New +$679K 0.03% 826
2017
Q4 		– Sell
-5,276
Closed -$483K – 1725
2017
Q3 		$483K Buy
5,276
+1,488
+39% +$114K 0.02% 838
2017
Q2 		$250K Sell
3,788
-289
-7% -$35.8K 0.01% 1081
2017
Q1 		$884K Sell
4,077
-1,056
-21% -$151K 0.04% 603
2016
Q4 		$474K Buy
5,133
+3,677
+253% +$414K 0.03% 774
2016
Q3 		$196K Sell
1,456
-7,818
-84% -$776K 0.06% 497
2016
Q2 		$939K Buy
+9,274
New +$1.15M 0.05% 572
2016
Q1 		– Sell
-2,285
Closed -$748K – 1701
2015
Q4 		$748K Buy
+2,285
New +$744K 0.04% 687

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
IFG
Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

A.R.T. Advisors's LUMO Position: Q1 2020 in Review

A.R.T. Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 2,008 shares — an estimated $46K sold.

A.R.T. Advisors first reported a position in LUMO in Q4 2015 and held it in 11 quarters. The position peaked at $939K in Q2 2016. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

  • A.R.T. Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 2,008 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $46K.
  • A.R.T. Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2015 and held it in 11 quarters.
  • A.R.T. Advisors's Lumos Pharma, Inc. Common Stock position peaked at $939K in Q2 2016.
  • 46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.